Back to Treatments

Treatment

Recombinant Factor VIII

1
Conditions
351
Trials
50K
Participants
65%
Average Safety

Condition Evidence

Hemophilia

351 trials · 50K participants

90% effectiveness · 65% safety
Recombinant Factor VIII | DFDA